We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
Scope of the review of the evidence for dependence on, and withdrawal from, prescribed medicines.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
You must get permission to export certain drugs and medicines.
How to apply for, update and cancel licences for the manufacture, import and wholesale of human and veterinary medicines.
Check if someone selling medicines online in Northern Ireland is allowed to do so by the Medicines and Healthcare products Regulatory Agency (MHRA)
NHS Business Services Authority contact number for ordering prepaid prescriptions for 3 or 12 months at a cheaper rate than single prescriptions
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
It's illegal to drive if you're unfit to do so because you're on legal or illegal drugs, or you have certain levels of drugs or medicine in your blood
A series of indicators to inform safer prescribing practice to help pharmacists, clinicians and patients review prescribed medication and prevent harm.
How the MHRA makes decisions on what is a medicinal product (borderline products).
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
How to prepare for implementation and compliance of the Safety Features Regulation.
Information about new applications, post-licensing, advertising, product information and fees.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
Plans to make better use of pharmacies, improve access to primary care and maximise the contribution of pharmacy professionals set out in new consultation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.